Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S

被引：0
|
作者：
Osoegawa, A. [1 ]
Hashimoto, T. [1 ]
Takumi, Y. [1 ]
Kobayashi, R. [1 ]
Miyawaki, M. [1 ]
Takeuchi, H. [1 ]
Okamoto, T. [1 ]
Sugio, K. [1 ]
机构：
[1] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Yufu, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Acquired resistance; EGFR-TKI; PTEN;
D O I：
10.1016/j.jtho.2017.09.1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02-039
引用
收藏
页码：S2251 / S2251
页数：1
相关论文
共 50 条
  • [1] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Yamada, Tomonori
    Hashimoto, Takafumi
    Takumi, Yohei
    Kobayashi, Ryoji
    Suehiro, Shuji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    [J]. CANCER SCIENCE, 2018, 109 : 1101 - 1101
  • [3] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Atsushi Osoegawa
    Takafumi Hashimoto
    Yohei Takumi
    Miyuki Abe
    Tomonori Yamada
    Ryoji Kobayashi
    Michiyo Miyawaki
    Hideya Takeuchi
    Tatsuro Okamoto
    Kenji Sugio
    [J]. Investigational New Drugs, 2018, 36 : 999 - 1005
  • [4] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Yamada, Tomonori
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 999 - 1005
  • [5] Noninvasive analysis of acquired resistance to EGFR-TKI
    Kimura, Hideharu
    Nishio, Makoto
    Daito, Tsutomu
    Nishio, Kazuto
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [6] Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patients
    Zhuang, W.
    Xu, C.
    Wang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] Acquired resistance in NSCLC with EGFR mutation treated with TKI's
    Lueers, A.
    Hallas, C.
    Henke, R. -P
    Falk, M.
    Tiemann, M.
    Griesinger, F.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 6 - 6
  • [8] Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
    Zhang, P.
    Tu, L.
    Liu, R.
    Xu, X.
    Bao, Z.
    Xu, P.
    Wang, J.
    Li, H.
    Zhou, J.
    Wang, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S402 - S403
  • [9] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
    Izumi, Hiroto
    Kanda, Rina
    Murakami, Yuichi
    Morimoto, Yasuo
    Ono, Mayumi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [10] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
    Izumi, Hiroto
    Kanda, Rina
    Murakami, Yuichi
    Morimoto, Yasuo
    Ono, Mayumi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345